TGFB1 and neoplasm: Tregs produce immunosuppressive cytokines (IL-10, TGF-β), express coinhibitory molecules (CTLA-4, PD-1, PD-L1), and capture the Th1 cytokine IL-2, thereby inhibiting T cell-mediated responses and promoting immune escape of the tumor [64].